Breast Cancer: Menopausal Hormone Replacement Therapy Risks ‘Bigger Than Thought’

NEWS

The increased risk of breast cancer from menopausal hormone replacement therapy lasts more than a decade after treatment stops, a major report suggests.

COMMENT

As Dr. Rath explains in chapter 9 of his book, ‘Why Animals Don’t Get Heart Attacks…But People Do’, long-term intake of estrogen and other hormones — both as hormonal contraception and hormone replacement therapy — causes a depletion of vitamins and other cellular nutrients in the body. This is the real reason why women taking hormone-based pills have an increased risk not just of cancer but also heart attacks, strokes and other forms of cardiovascular disease.

As long ago as 1972, a report in the scientific journal Nature described how women taking hormonal contraceptives had significantly lower vitamin C blood levels than normal. The fact is that long-term use of hormonal drugs decreases the body pool of vitamin C and other essential micronutrients, such as B vitamins and calcium. Thus, it is not the hormones themselves that increase the risk of cancer and other diseases, but the associated depletion of micronutrients.

For women who have been taking hormonal birth control pills or have undergone hormone replacement therapy, Dr. Rath’s recommendation is that they start following his Cellular Health recommendations in order to replenish their body’s vitamin pool and prevent its future depletion.